Multiplex Base Editing to Protect from CD33-Directed Therapy: Implications for Immune and Gene Therapy
F. Borot, O. Humbert, G. A. Newby, E. Fields, S. Kohli, S. Radtke, G. S. Laszlo, T. Mayuranathan, A. M. Ali, M. J. Weiss, J. S. Yen, R. B. Walter, D. R. Liu, S. Mukherjee, H.-P. Kiem
The paper develops a base editing approach to reduce on-target toxicity in CD33-directed therapies by editing CD33 and gamma globin genes in hematopoietic stem and progenitor cells.
bioRxiv · Feb 23, 2023 · PreprintCell Biology